Plain-English translation of NCT04572750 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Anxiety research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tested an electronic app called EMPOWER-ED, designed to help people reduce their use of benzodiazepines — medications commonly prescribed for anxiety and sleep. The app was adapted from a paper-based program and converted to work on smartphones, tablets, and computers so Veterans could use it on their preferred device. The study examined whether this self-guided tool could help people safely taper down or stop taking this medication after using it long-term.
Benzodiazepines can be helpful for short-term use, but when taken for months or years, they carry serious risks including memory problems, confusion, increased fall risk, and overdose — especially when combined with opioids. The VA prescribes this medication to hundreds of thousands of Veterans annually, and most take it long-term, so there was a need for an effective, accessible tool to help people safely reduce their dependence.
Participants in this trial were randomly assigned to either receive access to the EMPOWER-ED app on their preferred device or to continue with their regular VA care. Those who received the app used it as a self-guided tool to help them gradually reduce their benzodiazepine use at their own pace. The study measured whether people who used the app were more successful at reducing or stopping their medication compared to those who received standard care.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States